Tekmira provides periodic update to shareholders regarding litigation

RELATED QUOTES

SymbolPriceChange
TKMR4.73-0.01

Tekmira Pharmaceuticals provided a periodic update to its shareholders on the ongoing litigation with Alnylam Pharmaceuticals (AMLN) and AlCana Technologies. CEO Dr. Mark J. Murray commented: "We are firmly committed to regaining control of our LNP technology and preserve its full value for Tekmira. The Massachusetts Superior Court has issued a pre-trial scheduling order with the timeline for the remaining pre-trial events leading up to a trial commencing on Nov. 14, 2012."

  •  
    Recent Quotes
    Symbol Price Change % ChgChart 
    Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
    You need to enable your browser cookies to view your most recent quotes.
  • Recent Quotes News

    •  
      Sign-in to view quotes in your portfolios.

    Trading Center

    Yahoo! Finance on Facebook

    POLL

    What would you like to see out of any potential tax reforms?

    Loading...
    Poll Choice Options